FDA approvals
Med-El USA’s cochlear implant (CI) system is approved for single-sided deafness (SSD) and asymmetric hearing loss (AHL). CI’s Synchrony and recently FDA-approved Synchrony-2 are now indicated for individuals 5 years and older with SSD who have profound sensorineural hearing loss in one ear and normal hearing or mild sensorineural hearing loss in the other ear, or individuals 5 years and older with AHL who have profound sensorineural hearing loss in one ear and mild to moderately severe sensorineural hearing loss in the other ear, with a difference of at least 15dB in pure tone averages between ears.
B. Braun Interventional Systems Inc. (BIS) was granted Breakthrough Device Designation for its SeQuent Please ReX percutaneous transluminal coronary angioplasty (PCTA) drug-coated balloon (DCB) catheter for the treatment of coronary in-stent restenosis (ISR). Breakthrough designation will streamline the review process and timeline for bringing the treatment option to patients.Certifications
Florida Anodize System & Technologies Inc.’s quality management system for its medical device surface coating services was audited by TUV SUD and found to be in full compliance with ISO 13485:2016.
Nanotech Precision, a manufacturer of micro-sized instruments and electrodes, has received ISO 13485:2016 for medical devices and quality management systems.
Explore the September 2019 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- A Primer on Defense Contract Manufacturing
- September 2024 USMTO orders up from August 2024; up from September 2023
- Sandvik Coromant's automatic tool change (ATC) for turning centers
- IMTS 2024 Booth Tour: Vollmer
- Supply chain vulnerabilities amid rising cyberattacks
- CERATIZIT’s UP2DATE solutions for micromachining, milling titanium, finishing steel
- IMTS 2024 Booth Tour: Hurco
- HANNOVER MESSE 2025 presents digital ecosystems